OTCMKTS:OCPNY Olympus (OCPNY) Stock Price, News & Analysis $18.00 -0.25 (-1.37%) As of 01/31/2023 Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Olympus Stock (OTCMKTS:OCPNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Olympus alerts:Sign Up Key Stats Today's Range$18.00▼$18.0050-Day Range$18.00▼$18.0052-Week Range$16.80▼$74.99Volume400 shsAverage Volume860,265 shsMarket Capitalization$23.15 billionP/E Ratio21.95Dividend Yield0.44%Price TargetN/AConsensus RatingN/A Company OverviewOlympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.Read More… Receive OCPNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter. Email Address OCPNY Stock News HeadlinesMonroe Capital Supports Olympus Partners' Acquisition of Accelevation Holding Company, LLCFebruary 18, 2025 | businesswire.comOlympus Corporation (OLYMY) Q3 2025 Earnings Call TranscriptFebruary 14, 2025 | seekingalpha.comHere’s How to Claim Your Stake in Elon’s Private Company, xAIElon Musk has done it again. He’s developed a powerful new AI model that’s already turning heads — and turning the industry upside down. Some say it could threaten Google’s search engine dominance. Others believe it could mark the beginning of the end for ChatGPT.April 26, 2025 | Brownstone Research (Ad)Olympus Corporation (OLYMY) Q2 2025 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comTim Stroble Appointed as Olympus Insurance Company Chief Executive OfficerMay 11, 2023 | finance.yahoo.comNew Olympus sports complex partnership is latest in $1B+ project's progressFebruary 26, 2023 | bizjournals.comOlympus Teams Up With Sony for Surgical Big Screen TVFebruary 23, 2023 | thestreet.comOlympus says addressing FDA concerns on endoscope productionJanuary 12, 2023 | seekingalpha.comSee More Headlines OCPNY Stock Analysis - Frequently Asked Questions How have OCPNY shares performed this year? Olympus' stock was trading at $18.00 on January 1st, 2025. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00. View the best growth stocks for 2025 here. How were Olympus' earnings last quarter? Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings results on Thursday, August, 5th. The company reported $0.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.03. The company had revenue of $1.75 billion for the quarter, compared to analysts' expectations of $1.49 billion. Olympus had a trailing twelve-month return on equity of 24.30% and a net margin of 13.80%. Does Olympus have any subsidiaries? Olympus subsidiaries include these companies: FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more. How do I buy shares of Olympus? Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/05/2021Today4/25/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Structural clay products Sub-IndustryN/A Current SymbolOTCMKTS:OCPNY CIKN/A Webwww.olympus-global.com Phone(133) 340-2111Fax813-3340-2062Employees31,557Year Founded1919Profitability EPS (Most Recent Fiscal Year)$0.82 Trailing P/E Ratio21.95 Forward P/E Ratio10.91 P/E Growth1.07Net Income$1.03 billion Net Margins13.80% Pretax MarginN/A Return on Equity24.30% Return on Assets9.30% Debt Debt-to-Equity Ratio0.59 Current Ratio1.99 Quick Ratio1.48 Sales & Book Value Annual Sales$7.74 billion Price / Sales2.99 Cash Flow$1.22 per share Price / Cash Flow14.76 Book Value$3.50 per share Price / Book5.14Miscellaneous Outstanding Shares1,285,890,000Free FloatN/AMarket Cap$23.15 billion OptionableNot Optionable Beta0.70 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:OCPNY) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olympus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olympus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.